212 related articles for article (PubMed ID: 22948151)
1. Identification of HEXIM1 as a positive regulator of p53.
Lew QJ; Chia YL; Chu KL; Lam YT; Gurumurthy M; Xu S; Lam KP; Cheong N; Chao SH
J Biol Chem; 2012 Oct; 287(43):36443-54. PubMed ID: 22948151
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitination of HEXIM1 by HDM2.
Lau J; Lew QJ; Diribarne G; Michels AA; Dey A; Bensaude O; Lane DP; Chao SH
Cell Cycle; 2009 Jul; 8(14):2247-54. PubMed ID: 19617712
[TBL] [Abstract][Full Text] [Related]
3. Nucleophosmin interacts with HEXIM1 and regulates RNA polymerase II transcription.
Gurumurthy M; Tan CH; Ng R; Zeiger L; Lau J; Lee J; Dey A; Philp R; Li Q; Lim TM; Price DH; Lane DP; Chao SH
J Mol Biol; 2008 Apr; 378(2):302-17. PubMed ID: 18371977
[TBL] [Abstract][Full Text] [Related]
4. HEXIM1, a New Player in the p53 Pathway.
Lew QJ; Chu KL; Chia YL; Cheong N; Chao SH
Cancers (Basel); 2013 Jul; 5(3):838-56. PubMed ID: 24202322
[TBL] [Abstract][Full Text] [Related]
5. The RASSF6 tumor suppressor protein regulates apoptosis and the cell cycle via MDM2 protein and p53 protein.
Iwasa H; Kudo T; Maimaiti S; Ikeda M; Maruyama J; Nakagawa K; Hata Y
J Biol Chem; 2013 Oct; 288(42):30320-30329. PubMed ID: 24003224
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA.
Yik JH; Chen R; Nishimura R; Jennings JL; Link AJ; Zhou Q
Mol Cell; 2003 Oct; 12(4):971-82. PubMed ID: 14580347
[TBL] [Abstract][Full Text] [Related]
7. Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein.
Bartholomeeusen K; Xiang Y; Fujinaga K; Peterlin BM
J Biol Chem; 2012 Oct; 287(43):36609-16. PubMed ID: 22952229
[TBL] [Abstract][Full Text] [Related]
8. HEXIM1 induces differentiation of human pluripotent stem cells.
Ding V; Lew QJ; Chu KL; Natarajan S; Rajasegaran V; Gurumurthy M; Choo AB; Chao SH
PLoS One; 2013; 8(8):e72823. PubMed ID: 23977357
[TBL] [Abstract][Full Text] [Related]
9. Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.
Neo SH; Lew QJ; Koh SM; Zheng L; Bi X; Chao SH
Oncotarget; 2016 Feb; 7(5):5483-94. PubMed ID: 26734838
[TBL] [Abstract][Full Text] [Related]
10. An alpha-herpesvirus employs host HEXIM1 to promote viral transcription.
Wu Y; Sun A; Yang Q; Wang M; Tian B; Yang Q; Jia R; Chen S; Ou X; Huang J; Sun D; Zhu D; Liu M; Zhang S; Zhao X-X; He Y; Wu Z; Cheng A
J Virol; 2024 Mar; 98(3):e0139223. PubMed ID: 38363111
[TBL] [Abstract][Full Text] [Related]
11. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.
Gomes NP; Bjerke G; Llorente B; Szostek SA; Emerson BM; Espinosa JM
Genes Dev; 2006 Mar; 20(5):601-12. PubMed ID: 16510875
[TBL] [Abstract][Full Text] [Related]
12. Regulation of polymerase II transcription by 7SK snRNA: two distinct RNA elements direct P-TEFb and HEXIM1 binding.
Egloff S; Van Herreweghe E; Kiss T
Mol Cell Biol; 2006 Jan; 26(2):630-42. PubMed ID: 16382153
[TBL] [Abstract][Full Text] [Related]
13. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
14. HDMX-L is expressed from a functional p53-responsive promoter in the first intron of the HDMX gene and participates in an autoregulatory feedback loop to control p53 activity.
Phillips A; Teunisse A; Lam S; Lodder K; Darley M; Emaduddin M; Wolf A; Richter J; de Lange J; Verlaan-de Vries M; Lenos K; Böhnke A; Bartel F; Blaydes JP; Jochemsen AG
J Biol Chem; 2010 Sep; 285(38):29111-27. PubMed ID: 20659896
[TBL] [Abstract][Full Text] [Related]
15. L-GILZ binds p53 and MDM2 and suppresses tumor growth through p53 activation in human cancer cells.
Ayroldi E; Petrillo MG; Bastianelli A; Marchetti MC; Ronchetti S; Nocentini G; Ricciotti L; Cannarile L; Riccardi C
Cell Death Differ; 2015 Jan; 22(1):118-30. PubMed ID: 25168242
[TBL] [Abstract][Full Text] [Related]
16. HEXIM1 regulates 17beta-estradiol/estrogen receptor-alpha-mediated expression of cyclin D1 in mammary cells via modulation of P-TEFb.
Ogba N; Chaplin LJ; Doughman YQ; Fujinaga K; Montano MM
Cancer Res; 2008 Sep; 68(17):7015-24. PubMed ID: 18757415
[TBL] [Abstract][Full Text] [Related]
17. Novel insights into transcriptional elongation: ubiquitination of HEXIM1 and p-TEFb activity.
Kehn-Hall K; Kashanchi F
Cell Cycle; 2009 Aug; 8(16):2485. PubMed ID: 19684463
[No Abstract] [Full Text] [Related]
18. HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function.
Lau LM; Nugent JK; Zhao X; Irwin MS
Oncogene; 2008 Feb; 27(7):997-1003. PubMed ID: 17700533
[TBL] [Abstract][Full Text] [Related]
19. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of nutlin-induced apoptosis in multiple myeloma: evidence for p53-transcription-dependent and -independent pathways.
Saha MN; Jiang H; Chang H
Cancer Biol Ther; 2010 Sep; 10(6):567-78. PubMed ID: 20595817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
